Progenios ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark

 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.0% 5.6% 5.7% 5.1% 3.5%  
Credit score (0-100)  36 40 39 42 52  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,591 3,470 3,649 4,402 4,456  
EBITDA  103 680 377 340 568  
EBIT  68.7 637 325 290 519  
Pre-tax profit (PTP)  67.5 632.3 305.2 255.4 492.4  
Net earnings  51.7 491.1 236.2 197.0 382.1  
Pre-tax profit without non-rec. items  67.5 632 305 255 492  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  54.1 72.8 108 93.1 68.2  
Shareholders equity total  284 575 412 259 641  
Interest-bearing liabilities  1.4 6.2 362 595 434  
Balance sheet total (assets)  1,192 2,181 1,932 1,724 1,870  

Net Debt  -259 -701 306 352 197  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,591 3,470 3,649 4,402 4,456  
Gross profit growth  42.2% 33.9% 5.1% 20.6% 1.2%  
Employees  4 4 5 6 6  
Employee growth %  33.3% 0.0% 25.0% 20.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,192 2,181 1,932 1,724 1,870  
Balance sheet change%  51.3% 82.9% -11.4% -10.8% 8.5%  
Added value  102.6 680.4 377.4 342.6 568.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -68 -25 -17 -65 -74  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2.7% 18.4% 8.9% 6.6% 11.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  7.2% 37.8% 15.8% 15.9% 28.9%  
ROI %  22.7% 146.9% 48.1% 35.7% 53.8%  
ROE %  16.6% 114.2% 47.9% 58.8% 85.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  23.8% 26.4% 21.3% 15.0% 34.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -252.8% -103.1% 81.2% 103.3% 34.7%  
Gearing %  0.5% 1.1% 88.0% 230.1% 67.7%  
Net interest  0 0 0 0 0  
Financing costs %  205.4% 127.1% 11.2% 7.4% 5.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 1.3 1.2 1.1 1.4  
Current Ratio  1.2 1.3 1.2 1.1 1.4  
Cash and cash equivalent  260.7 707.5 55.7 243.3 237.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  212.2 472.4 273.3 135.3 542.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  26 170 75 57 95  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  26 170 75 57 95  
EBIT / employee  17 159 65 48 86  
Net earnings / employee  13 123 47 33 64